Literature DB >> 20530732

Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration.

Garry Milman1, Allan J Barnes, David M Schwope, Eugene W Schwilke, William D Darwin, Robert S Goodwin, Deanna L Kelly, David A Gorelick, Marilyn A Huestis.   

Abstract

BACKGROUND: Oral fluid, a promising alternative matrix for drug monitoring in clinical and forensic investigations, offers noninvasive sample collection under direct observation. Cannabinoid distribution into oral fluid is complex and incompletely characterized due to the lack of controlled drug administration studies.
METHODS: To characterize cannabinoid disposition in oral fluid, we administered around-the-clock oral Delta(9)-tetrahydrocannabinol (THC) (Marinol) doses to 10 participants with current daily cannabis use. We obtained oral fluid samples (n=440) by use of Quantisal collection devices before, during, and after 37 20-mg THC doses over 9 days. Samples were extracted with multiple elution solvents from a single SPE column and analyzed by 2-dimensional GC-MS with electron-impact ionization for THC, 11-hydroxy-THC (11-OH-THC), cannabidiol, and cannabinol and negative chemical ionization for 11-nor-9-carboxy-THC (THCCOOH). Linear ranges were 0.5-50 microg/L, with the exception of cannabinol (1-50 microg/L) and THCCOOH (7.5-500 ng/L).
RESULTS: THCCOOH was the most prevalent analyte in 432 samples (98.2%), with concentrations up to 1117.9 ng/L. In contrast, 11-OH-THC was not identified in any sample; cannabidiol and cannabinol were quantified in 3 and 8 samples, respectively, with maximum concentrations of 2.1 and 13 microg/L. THC was present in only 20.7% of samples, with highest concentrations near admission (median 4.2 microg/L, range 0.6-481.9) from previously self-administered smoked cannabis.
CONCLUSIONS: Measurement of THCCOOH in OF not only identifies cannabis exposure, but also minimizes the possibility of passive inhalation. THCCOOH may be a better analyte for detection of cannabis use.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530732      PMCID: PMC3171507          DOI: 10.1373/clinchem.2009.141853

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  29 in total

Review 1.  Interpretation of oral fluid tests for drugs of abuse.

Authors:  Edward J Cone; Marilyn A Huestis
Journal:  Ann N Y Acad Sci       Date:  2007-03-01       Impact factor: 5.691

2.  Delta-9-tetrahydrocannabinol. Temporal correlation of the psychologic effects and blood levels after various routes of administration.

Authors:  L Lemberger; J L Weiss; A M Watanabe; I M Galanter; R J Wyatt; P V Cardon
Journal:  N Engl J Med       Date:  1972-03-30       Impact factor: 91.245

3.  Detection of cannabis in oral fluid (saliva) and forehead wipes (sweat) from impaired drivers.

Authors:  P Kintz; V Cirimele; B Ludes
Journal:  J Anal Toxicol       Date:  2000-10       Impact factor: 3.367

4.  Detection of THCA in oral fluid by GC-MS-MS.

Authors:  David Day; David J Kuntz; Michael Feldman; Lance Presley
Journal:  J Anal Toxicol       Date:  2006 Nov-Dec       Impact factor: 3.367

5.  Evaluating the impact of hemp food consumption on workplace drug tests.

Authors:  G Leson; P Pless; F Grotenhermen; H Kalant; M A ElSohly
Journal:  J Anal Toxicol       Date:  2001 Nov-Dec       Impact factor: 3.367

6.  Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid.

Authors:  Gerold F Kauert; Johannes G Ramaekers; Erhard Schneider; Manfred R Moeller; Stefan W Toennes
Journal:  J Anal Toxicol       Date:  2007-06       Impact factor: 3.367

7.  Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry.

Authors:  Garry Milman; Allan J Barnes; Ross H Lowe; Marilyn A Huestis
Journal:  J Chromatogr A       Date:  2010-01-04       Impact factor: 4.759

8.  Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC.

Authors:  Eugene W Schwilke; David M Schwope; Erin L Karschner; Ross H Lowe; William D Darwin; Deanna L Kelly; Robert S Goodwin; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2009-10-15       Impact factor: 8.327

9.  Detection of conjugated 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid.

Authors:  Christine Moore; Sumandeep Rana; Cynthia Coulter; David Day; Michael Vincent; James Soares
Journal:  J Anal Toxicol       Date:  2007-05       Impact factor: 3.367

Review 10.  Oral fluid testing for drugs of abuse.

Authors:  Wendy M Bosker; Marilyn A Huestis
Journal:  Clin Chem       Date:  2009-09-10       Impact factor: 8.327

View more
  19 in total

1.  Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration.

Authors:  Garry Milman; Allan J Barnes; David M Schwope; Eugene W Schwilke; Robert S Goodwin; Deana L Kelly; David A Gorelick; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2011-06-03       Impact factor: 4.142

2.  Cannabinoid disposition in oral fluid after controlled smoked cannabis.

Authors:  Dayong Lee; David M Schwope; Garry Milman; Allan J Barnes; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2012-01-24       Impact factor: 8.327

3.  Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis.

Authors:  Garry Milman; David M Schwope; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chim Acta       Date:  2012-01-20       Impact factor: 3.786

4.  Cannabinoid stability in authentic oral fluid after controlled cannabis smoking.

Authors:  Dayong Lee; Garry Milman; David M Schwope; Allan J Barnes; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2012-04-24       Impact factor: 8.327

5.  Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?

Authors:  Dayong Lee; Erin L Karschner; Garry Milman; Allan J Barnes; Robert S Goodwin; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2012-11-10       Impact factor: 4.492

6.  Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration.

Authors:  Dayong Lee; Ryan Vandrey; Garry Milman; Mateus Bergamaschi; Damodara R Mendu; Jeannie A Murray; Allan J Barnes; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2013-07-06       Impact factor: 4.142

7.  Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration.

Authors:  Madeleine J Swortwood; Matthew N Newmeyer; Maria Andersson; Osama A Abulseoud; Karl B Scheidweiler; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2016-10-13       Impact factor: 3.345

8.  Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers.

Authors:  Sebastien Anizan; Garry Milman; Nathalie Desrosiers; Allan J Barnes; David A Gorelick; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2013-08-17       Impact factor: 4.142

9.  Cannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokers.

Authors:  Matthew N Newmeyer; Nathalie A Desrosiers; Dayong Lee; Damodara R Mendu; Allan J Barnes; David A Gorelick; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2014-03-20       Impact factor: 3.345

10.  11-Nor-9-carboxy-∆9-tetrahydrocannabinol quantification in human oral fluid by liquid chromatography-tandem mass spectrometry.

Authors:  Karl B Scheidweiler; Sarah K Himes; Xiaohong Chen; Hua-Fen Liu; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2013-05-17       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.